EXPERT

Les résultats de cette étude pourraient influencer la façon dont sont traitées 2 femmes sur 5 atteintes d’un cancer du sein.

Mother and daughter having good time together

The results of the EXPERT academic study could influence how 2 in 5 women with breast cancer are treated by identifying which women could be spared unnecessary radiation therapy after surgery in the future.

Partager cette page

Female chest, symbol illustrating women diagnosed with breast cancer
0
women to be involved
Microscope, symbol illustrating research
0
groupes membres
Globe, symbol illustrating international collaboration
0
pays
Stethoscop, symbol illustrating breast cancer experts
0
hôpitaux

The EXPERT academic study – which will involve 1,170 women from 90 hospitals and breast cancer centres linked to 8 groups from 8 countries around the globe – aims to better analyse the risk profile of breast cancer tumours in order to identify which women could be spared radiation therapy in the future. This study is coordinated and sponsored by the Breast Cancer Trials – Australia & New Zealand (BCT-ANZ) in collaboration with BIG.

Actuellement, pour de nombreux patients atteints d’un cancer du sein à un stade précoce, la norme en matière de traitement consiste en de la radiothérapie associée à un traitement endocrinien, après ablation chirurgicale de la tumeur. Cependant, le bénéfice réel de la radiothérapie varie considérablement d’un malade à l’autre. Les patients présentant un faible risque de récidive sont ainsi potentiellement surtraités et exposés inutilement aux effets secondaires associés à la radiothérapie.

The prospect of safely de-escalating radiation therapy is of great interest to many patients, who will appreciate not being subjected to a treatment that will not benefit them significantly if their tumours are low-risk, while ensuring that patients at greater risk of relapse do receive treatment of an appropriate intensity.

Aidez-nous à sauver des vies et à faire avancer la recherche sur le cancer du sein